Nokia Corporation (NYSE:NOK) Hits Multi-Month High - HTZ, KNXA, ZLCS, HCBK

Nokia Corporation (ADR) (NYSE:NOK) shares jumped 10.03% to $3.39 after Apple Inc.(NASDAQ:AAPL) defeated Samsung in a critical patents war. Nokia shares are gaining because that’s what they’ve plumped for. the theory would have to be that the company made the right bet in deciding to adopted Windows Phone as the the OS for its smartphones, rather than Android – and that it could take some market share in the U.S. and possibly elsewhere if Android phones run into ongoing patent issues trying to compete against Apple.

The $1 billion jury verdict in favor of Apple Inc. (AAPL) on Friday, has given rise to debate over the future of the smartphone industry in the United States in general and Android devices in particular.

Can NOK Continue To Hit New Highs? Find Out Here

Hertz Global Holdings, Inc. (NYSE:HTZ) shares jumped 15.97% to $15.26 in the morning hour after the company said it had signed a deal to buy rival Dollar Thrifty Automotive Group Inc. for approximately $2.3 billion in cash or $87.50 a share. The deal represents a premium over Dollar Thrifty’s closing price Friday. The company also said it had struck a separate agreement to sell its Advantage unit to Franchise Services of North America and Macquarie Capital.

Can NOK Continue To Hit New Highs? Find Out Here

Kenexa Corporation (NYSE:KNXA) stock soared 41.22% to $45.74 after IBM and Kenexa Corporation announced that they have entered into a definitive agreement for IBM to acquire Kenexa, in a cash transaction at a price of $46 per share, or at a net price of approximately $1.3 billion. IBM said the Kenexa acquisition will complement its social business and HR business services leadership.

Zalicus Inc (NASDAQ:ZLCS) stock gained 14.29% to $1.44. The company announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.

Hudson City Bancorp, Inc. (NASDAQ:HCBK) shares climbed 14.93% to $7.40 in the early hour after M&T Bank Corp said it would buy Hudson City Bancorp Inc in a deal valued at about $3.7 billion, expanding its franchise in the eastern United States. M&T expects to gain about $25 billion in deposits and $28 billion in loans from the merger. The transaction is expected to be immediately accretive to the combined company's capital ratios, as well as its GAAP and operating earnings per share.